1. The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway.
   Chung-Yi Chen et al, 2018, Int J Mol Sci CrossRef
2. Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells
   Hanna Maja Tunset et al, 2019, IJMS CrossRef
3. Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer
   Yukiko Nishiguchi et al, 2019, IJMS CrossRef
4. Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
   Katarzyna Skorka et al, 2021, JCM CrossRef
5. ERα36–GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells
   George Notas et al, 2021, IJMS CrossRef
6. Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base
   Catalin I. Efrimescu et al, 2021, Curr Oncol Rep CrossRef
7. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
   Concetta Saponaro et al, 2021, Front. Oncol. CrossRef
8. Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
   Mariya Farooq et al, 2021, Front. Cell Dev. Biol. CrossRef
9. Platelet Toll-like Receptor 4–Related Innate Immunity Potentially Participates in Transfusion Reactions Independent of ABO Compatibility: An Ex Vivo Study
   Chien-Sung Tsai et al, 2021, Biomedicines CrossRef
10. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
    Xiong Zou et al, 2022, Front. Mol. Biosci. CrossRef
11. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
    Jing Shen et al, 2022, Front. Oncol. CrossRef
12. Understanding and harnessing triple-negative breast cancer-related microbiota in oncology.
    Ciaran Devoy et al, 2022, Front Oncol CrossRef
13. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages
    Chandan Mahish et al, 2023, Front. Immunol. CrossRef
14. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
    Arianna Giacomini et al, 2023, Exp Hematol Oncol CrossRef
15. MyD88 signaling pathways: role in breast cancer.
    Hongmei Zheng et al, 2024, Front Oncol CrossRef
16. Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis
    Si-Jun Bai et al, 2024, Ann Hematol CrossRef
17. Pyroptosis and its therapeutic potential
    I. A. Odintsova et al, 2024, Bûll. sib. med. CrossRef
18. A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response
    Xuewu Tang, 2024, Am J Cancer Res CrossRef
19. Quercetin Modulates the Signalling Pathways and Therapeutic Targets in the Pathophysiology of Lung Cancer: A Systematic Review
    Seyed Vahid Jasemi et al, 2024, LDDD CrossRef
20. FSTL1 and TLR4 interact with PEDV structural proteins to promote virus adsorption to host cells
    Chunyun Liu et al, 2024, J Virol CrossRef
21. RAGE and its ligands in breast cancer progression and metastasis
    Madalina Coser et al, 2025, Oncol. Rev. CrossRef